Plandai Biotechnology, Inc. Receives Approval to Grow Cannabis for Medical Research From Uruguay's Ministry of Public Health
29 oct. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - October 29, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), a developer of highly bioavailable plant extracts for industries including...
Plandai Biotechnology's Technology Could Prove Potent in Battling Alzheimers Disease
21 oct. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - October 21, 2014) - In the recently released preliminary results from Plandaí Biotechnology's (OTCQB: PLPL) human clinical trial that compared its green tea extract to a...
Plandai Biotechnology Marketing of First Product to Customers Should Be a Cinch With Proven Higher Bioavailability
17 oct. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - October 17, 2014) - Plandaí Biotechnology (OTCQB: PLPL) began to lay out its initial plan this week explaining just how the company will get its first product, a green tea...
Plandai Biotechnology, Inc. Announces Update on Factory and Expected Plan to Market First Phytofare(TM) Product
15 oct. 2014 09h27 HE
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - October 15, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), a developer of highly bioavailable plant extracts for industries including...
Plandai Biotechnology's Green Tea Extract Delivers Favorable Preliminary Results in Human Clinical Trial Conducted in South Africa
10 sept. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 10, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently released the preliminary results from its human clinical trial where the company's green tea...
FDA Exemption Has Plandai Biotechnology Heading Into Third Quarter Ready to Commence Sales of First Phytofare(TM) Product
26 juin 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently learned that it qualifies for an exemption that will allow the company to commence sales of its...
Plandaí Biotechnology's VP of Global Marketing Jamen Shively Discusses Future of Cannabis at the Company
13 mai 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 13, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has plans to develop and market a cannabis extract once the political climate in the US sorts itself...
Plandai Biotechnology up for $2.5 Million Grant in Continued Support From South African Government
02 mai 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 2, 2014) - Plandaí Biotechnology (OTCQB: PLPL) could soon receive another injection of money from the South African government, and this time it's in the form...
Plandai Biotechnology Recruiting Now for Human Clinical Trials to Begin in May
30 avr. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 30, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has been given the go-ahead to conduct human clinical trials in a 3-month study that will compare the oral...
Plandai Biotechnology's Cannabis Extracts Could Further Shape Marijuana Debate
11 avr. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 11, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has a deal in place to brand and market its future cannabis extracts under the Diego Pellicer Gold label, and...